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1. INTRODUCTION  
Acute and chronic application of a great variety of stimuli to the brain have been shown to 
lead to differential responses reflecting short-term and long-term neural plasticity. Thus, the 
cellular consequences of repeated seizure activity characteristic of epilepsy differ from that 
of a single, acute seizure episode. This fact is demonstrable by the expression of 
transcription factors (TFs), proteins that control gene expression in response to receptor 
activation.  
Fos-family TFs exert their effects via heterodimeric complexes that constitute the activator 
protein -1 (AP-1) complex and activate or repress the transcription of many 
neurobiologically important target genes (Herdegen and Leah, 1998). While c-fos and full-
length FosB are induced rapidly and transiently in specific brain areas after different types 
of stimuli, the truncated form of FosB gene, named FosB, codes for a highly stable protein 
with a half-life of approximately 1 week and functions as a type of molecular switch that 
gradually converts acute responses into relatively stable adaptations that underlie long-term 
neural and behavioural plasticity to repeated stimuli (Nestler et al., 1999).  
The epileptogenic effects of the potassium channel blocker 4-aminopyridine (4-AP) has 
been extensively studied in acute experiments. The c-fos expression, that can be regarded as 
a tool to study neuronal activation and seizure spread (Morgan and Curran, 1991), has a 
characteristic pattern and is maximal at 1 3 h following systemic 4-AP administration in the 
hippocampus and neocortex (Miháy et al., 2001, 2005). However, repeatedly elicited 4-AP 
seizures are expected to cause qualitatively different cellular modifications as compared to a 
single seizure episode.  
The importance of gamma aminobutyric acid (GABA) systems in the control of neural 
activity and the suppression of epileptiform discharge is well established. It is less clear 
whether long term changes in the function of inhibitory systems play a role in the 
development of epilepsy. Though, literature data show, that GABA systems can be modified 
by seizure activity (Morimoto et al., 2004). Accordingly, a large number of studies focused 
on a specific group of fast spiking interneurons, which use mainly GABA and express the 
Ca++- binding protein parvalbumin (PV). Postseizure modification of the PV content could 
be both indicative of, and a reason for the alterations in their physiological function.                
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2. AIMS  
The present study comprises investigations directed towards revealing some features of the 
mechanisms and consequences of seizure activity in acute and chronic conditions.  
The K+ channel blocker 4-AP was used in order to initiate brief generalized seizures in rats. 
The differential response after varying number of convulsive episodes was investigated at 
behavioural and molecular level. 
The specific aims of the experiments were as follows:  
Investigation of the relevance of transcriptional regulation in the mechanism of 
seizure induction and seizure spread by detection of time-dependent c-fos 
expression.  
Characterization of a chronic seizure model in terms of transcriptional regulation 
after repeatedly induced seizures that imply long-term alterations in neural 
plasticity.  
Investigation of the effects of repeatedly induced seizures related to the inhibitory 
neuronal circuit by examination of changes of a subset of parvalbumin-containing 
neurons.                                 
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3. MATERIALS AND METHODS  
3.1. Experimental animals and their treatments  
Adult rats were housed in groups under standard conditions (temperature 23 °C, lights on 
from 06:00 to 18:00 h) and with free access to water and food. The animals were injected 
intraperitoneally with 0.067% (w/v) solution of the convulsant 4-AP (Sigma; St. Louis, MO, 
USA) dissolved in physiological saline (0.9% NaCl in distilled water). The applied dose was 
5 mg/kg body weight, as this concentration proved to be convulsive in previous studies 
(Mihály et al., 2001, 2005). Control animals received appropriate volumes of physiological 
saline. All procedures of the animal experiments were licensed by the Committee for 
Animals in Experimental Research, University of Szeged, according to the directive of the 
European Council (86/609/EEC) and to the Hungarian Animal Act. 
The investigations were conducted with the following experimental groups:  
15 Wistar rats were used for the immunodetection of c-fos 30 min, 1 h, 3 h, 5 h, 
and 8 h after a single injection of 4-AP.  
Male Wistar rats (150 180 g) were anaesthetized with Calypsol (100 mg/kg) plus 
atropine (0.01 mg/kg) given intraperitoneally (i.p.). The head of the animal was 
fixed in a stereotaxic frame, and following a vertical skin incision, the soft tissues 
and the temporalis muscle were cut in order to expose the temporal squama on the 
left side. The bone was cut with a dental drill, removed and the rhinal sulcus was 
identified. The cortical area inferior to the rhinal sulcus was electrocoagulated and 
suctioned (lateral entorhinal cortex ablation, LECA). The lesion of the LEC 
extended to all cortical layers and also the subcortical white matter, including the 
temporoammonic pathway. At the end of the procedure, the bone defect was 
covered with the temporalis muscle and skin was closed with clamps. In sham-
operated control (SOC) animals the same procedure was performed except for 
coagulation  the meninges and the brain were not injured. 40 days following the 
surgical destruction of the lateral entorhinal cortex (LECA) one group of Wistar 
rats (3 animals) received a single injection of 4-AP.  Three SOC rats received the 
same treatment. These rats were sacrificed 3 h after the treatment and their brains 
were processed for c-fos immunohistochemistry. 
Three groups of Wistar rats received daily 4-AP injections for 1, 4, 8 and 12 days 
and were sacrificed 24 h after the last injection to be investigated by FosB and PV 
immunodetection. 
Three groups of Sprague-Dawley rats were treated by daily injections of 4-AP for 
12 days and sacrificed 3 h after the last injection to be investigated by PV 
immunohistochemistry, Western blotting and in situ hybrization, respectively.  
For IHC, animals were deeply anesthetized with diethylether and perfused transcardially 
with 200 ml of 0.1 M phosphate buffered saline (PBS, pH 7.4), followed by 300 ml of 4% 
phosphate buffered paraformaldehyde (pH 7.4). The brains were removed and postfixed in 
4% phosphate buffered paraformaldehyde (pH 7.4) for 1h. After postfixation, the brains 
were cryoprotected overnight in 30% sucrose in 0.1 M phosphate buffer (pH 7.4).   
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3.2. Immunohistochemistry  
3.2.1. FosB immunolabeling 
Sections were incubated in 0.2% Triton X-100/PBS for 20 min, followed by washing in 
three changes of PBS. Then 20% normal pig serum (NPS; Sigma) was applied for 1 h to 
block nonspecific labeling. Sections from rats injected for 1, 4 and 8 days were used for 
immunohistochemical analysis of FosB protein, while sections from the rats treated for 12 
days were used for simple FosB and double FosB+parvalbumin immunolabeling. Since 
antibodies selective for FosB are not available, we used a rabbit polyclonal antiserum 
raised against an internal region of FosB (sc-48; Santa Cruz Biotechnology), that has been 
shown to recognize both FosB and FosB. The antibody was used diluted 1:4000 in 0.05M 
PBS containing 10% NPS. The sections were incubated in the primary antibody overnight at 
room temperature.  
The biotinylated secondary antibody (goat antirabbit IgG; Vector Laboratories, CA) was 
diluted 1:40 in PBS, and sections were incubated for 1 h. After additional washing, sections 
were transferred to streptavidin-peroxidase (1:1000; Jackson ImmunoResearch), and 
incubated for 1 h. Then the sections were washed and processed using 0.05% 3,3-
diaminobenzidine tetrahydrochloride (DAB; Sigma) containing 0.3% nickel sulphate and 
0.01% hydrogen peroxide. After 20 min of incubation, the chromogen yielded a black 
reaction product.  
The sections were dehydrated with an ascending series of ethanol (40%, 70% and 100%), 
cleared in xylene and mounted with Entellan (Fluka).  
3.2.2. C-fos immunolabeling 
Frozen, coronal plane sections were cut at 20 m thickness with cryostat. Polyclonal c-fos 
antibody (raised in rabbit; Santa Cruz Biotechnology, CA, USA) and the peroxidase-
antiperoxidase (PAP) method was used for immunohistochemistry. The sections were 
incubated in 20% normal pig serum, next in primary c-fos antibody (1:1000 in 20% normal 
pig serum), and then in donkey antirabbit IgG (1:40; Jackson Immuno-Research, PA, USA). 
The secondary antibody was detected by PAP complex diluted to 1:1000 (Jackson). The 
peroxidase reaction was localised with nickel chloride-containing diaminobenzidine 
tetrahydrochloride (Sigma), yielding a black reaction product.  
3.2.3. PV immunolabeling 
Coronal, frozen brain sections (24 m thin) were reacted with monoclonal mouse anti-PV 
antibody (Sigma PA-235, dilution 1:15,000). For the detection of the primary antibody, 
biotinylated goat anti-mouse IgG (Vector) and streptavidin-HRP (Vector) were employed. 
The immunoperoxidase reaction was developed by using 3 3 -diaminobenzidine 
tetrahydrochloride (DAB; Sigma) as a chromogen. The sections were mounted on 
microscope slides, dehydrated and coverslipped with Entellan (Fluka).  
3.2.4. PV and FosB double immunolabeling 
Double immunolabeling was performed using primary antibody cocktails: mouse anti-PV 
(Sigma), diluted 1:100,000 and rabbit anti-FosB (Santa Cruz Biotechnology), diluted 1:500. 
The sections were incubated in the primary antibody cocktail overnight at room temperature, 
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then transferred to the secondary antibody cocktail: biotinylated anti-mouse IgG (Sigma), 
diluted 1:600, and unlabeled goat anti-rabbit IgG (Vector Laboratories) diluted 1:40. The 
sections were incubated for 1 h in the secondary antibody cocktail and then transferred to 
streptavidin-peroxidase (1:1000; Jackson ImmunoResearch). The streptavidin-peroxidase 
was developed by using 0.05% DAB (Sigma) with 0.01% hydrogen peroxidase. Following a 
wash in TBS, the sections were transferred to peroxidase-anti-peroxidase (PAP; Jackson 
ImmunoResearch), diluted 1:1000, and incubated for 1 h. The PAP was developed using 
0.05% DAB (Sigma) with 0.3% nickel sulphate and 0.01% hydrogen peroxide, as described 
previously.     
3.3. Evaluation of immunolabeling and statistical analysis  
The quantitative analysis of each immunolabeling was performed on five histological 
sections per animal. The immunoreactive cells were counted using a Nikon Eclipse 600 
microscope equipped with a Spot RT Slider digital camera (1600x1200 dpi in 8 bits), and 
the Image Pro Plus 4 morphometry software (Media Cybernetics, Silver Spring, MD). 
Areas of interest were selected on the basis of the same stereotaxic coordinates (Paxinos and 
Watson, 1998): from regions CA1, CA2, CA3 of the Ammon s horn, the granule cell layer 
of the dentate gyrus, the hilum of the dentate gyrus, and from the neocortex.  
In the neocortex, the area of interest was the rectangular image-capturing field of the camera 
which included all neocortical layers (I VI) from the pia mater to the subcortical white 
matter. Frozen sections stained with cresyl violet were used as reference for the thickness of 
the neocortical layers. The counting was done by using a 10x objective. Following 
background subtraction, the threshold was adjusted so that all positively labeled cells could 
be recognized. Cell counts were then normalized to 1 mm2. 
In the hippocampus, the area of interest was the rectangular image-capturing field of the 
camera. The hilum of the dentate gyrus was outlined manually, according to Amaral (1978), 
and used as area of interest.  The counting was done by using a 40x objective. Following 
background subtraction, the threshold was adjusted so that all positively labeled cells could 
be recognized. Cell counts were then normalized to 1 mm2. 
In the mammillary bodies, the areas of interest (AOI) for cell counts were selected from the 
medial mammillary nucleus. Following background subtraction, the threshold was adjusted 
so that the counting program could equally recognize pale- and deep-stained cells. Cell 
counts were done using a 40x objective. The AOI was the rectangular image-capturing field 
of the camera (222 m x 296 m).  
The statistical analysis was performed with the SPSS 9.0 computer program.  
Differences of FosB, parvalbumin and double immunolabeling between control and 4-AP 
treated groups were analysed by a paired t-test in case of each time-course experiment. A 
significance criterion of p<0.05 was used. 
Differences in the number of c-fos IR cells in the control and convulsing animals were 
analysed with one-way analysis of variance (ANOVA), followed by the Bonferroni post hoc 
test.       
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3.4. Western blotting  
Rats in diethyl-ether anesthesia were decapitated 3 h after the last 4-AP or saline injection. 
The heads were immersed in liquid nitrogen, and the brains were dissected on ice. The 
mammillary area was cut out, chilled in liquid nitrogen and stored at -80 °C until use. The 
number of animals was 16: 8 treated with 4-AP for 12 days, and 8 controls (injected daily 
with saline for 12 days).  
The tissues were homogenized in 50 mM Tris HCl (pH 7.5) containing 2 mM 
phenylmethanesulfonyl fluoride (PMSF), 150 mM NaCl, 0.1% Nonidet-P-40, 2 g/ml 
leupeptin, 1 g/ml pepstatin and 2mM EDTA.  
Thirty-five micrograms protein was separated on a 10% SDS-polyacrylamide gel and 
transferred onto nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany). 
Membranes were blocked for 1 h in 5% nonfat dry milk in Tris HCl (pH 7.5) containing 
0.9% NaCl (TBS) and 0.05% Tween 20, and incubated overnight with mouse anti-PV 
antibody (Sigma PA-235; dilution 1:3000). After 5x5 min washes in TBS-Tween 20 on 
room temperature, the membranes were incubated for 1 h with biotinylated goat anti-mouse 
IgG (Vector Laboratories; Burlingame, CA, USA; dilution 1:1000), and washed three times 
as before.  
The enhanced chemiluminescence method (ECL Plus Western blotting detection reagents; 
Amersham Biosciences, Little Chalfont, Buckinghamshire, UK) was then used to reveal 
immunoreactive bands, according to the manufacturer s protocol. The other chemicals were 
from Sigma. The intensity of the bands was quantified by densitometry and expressed as 
pixel volume (pixel intensity x area) using the Gel-Doc system (Biorad). For quantitative 
comparisons, each value was calculated based on at least seven independent determinations.  
An analysis of variance (ANOVA) followed by post hoc analysis (Tukey s multiple 
comparison) was used to evaluate the significance.   
3.5. cRNA probes  
The only PV gene in the rat contains five exons and codes for two mRNA species by means 
of alternative polyadenylation. A template for a gene-specific cRNA probe was created by 
isolating the 133 bp long third exon of the rat PV gene by genomic polymerase chain 
reaction (PCR) using the primers 5 CCCCCCAACAGCTGCAGACTCC- 3 and 5 -
TTTACCCCAGCTCATCCTCCTCAATG- 3 . The PCR product was inserted into the 
pcDNA3 vector (Invitrogene, Carlsbad, CA) between BamHI and EcoRI restriction sites and 
cloned using standard methods. Identity of the insert was confirmed by sequencing (AB 373 
DNA Sequencer; PE Applied Biosystems, Foster City, CA). For the production of antisense 
and sense PV cRNA probes, the vector construct was linearized either with BamHI or EcoRI 
(Promega, Madison, WI, USA), respectively. Then, the linearized plasmid was transcribed 
in vitro by using Riboprobe System-T7 and Riboprobe System-SP6 (Promega) according to 
the manufacturer s instructions. For radiolabeling, [35S]UTP ´ S (ICN Biomedicals; Costa 
Mesa, CA) was incorporated during the syntheses of the cRNA probes. The antisense and 
sense PV [35S]cRNA probes were purified by size exclusion chromatography using 
ProbeQuant G-50 Sephadex microcolumns (Pharmacia Biotech; Uppsala, Sweden) and their 
specific activities were determined to be 3.1x107 6.4x107 cpm/ pmol by liquid scintillation 
counting.   
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3.6. In situ hybridization  
Coronal rat brain sections were fixed for 5 min in 2x SSC containing 4% formaldehyde at 
room temperature (RT) and washed twice in 2xSSC for 1 min at RT. Then, the sections were 
rinsed in 0.1 M triethanolamine containing 0.25% acetic anhydride and 0.9% NaCl, pH 8.0 
for 5 min at RT, dehydrated, and air-dried. Next, the sections were hybridized in 50 l 
hybridization solution (50% formamide, 6x SSPE, 5x Denhardt s reagent, 10% dextran 
sulfate, 50 mM DTT, 100 g/ml salmon sperm DNA, and 50 g/ml yeast tRNA) containing 
a [35S]cRNA probe. The concentrations of the PV antisense and sense hybridization 
solutions ranged from 247 to 288 fmol/ml. Hybridization was performed under Parafilm 
coverslips in a humid chamber at 55 °C for 24±0.5 h. The sections were rinsed once in 2x 
SSC/50% formamide at RT for 5 min, twice in 2x SSC/50% formamide at 50 °C for 10 min, 
and then in 2x SSC at RT for 5 min. The sections were next incubated in 1x TE containing 
0.5 M NaCl and 1.32x10-3 Kunitz U (~25 mg protein)/ml RNase A at 37 °C for 30 min, and 
rinsed in 2x SSC/50% formamide at 50 °C for 10 min and in 2x SSC at 50 °C for 10 min. 
Sections were dehydrated, air-dried and processed for phosphorimaging.                                
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4. RESULTS  
4.1. 4-AP-precipitated seizure behaviour   
1.1. Acute seizure model 
Following the injection of the convulsive dose of 4-AP, the animals displayed behavioural 
seizures which lasted for 60 80 min. The characteristic symptoms occured within 
approximately 10 min of injection and developed gradually, as described previously (Mihály 
et al., 1990). Initially, animals exhibited increased exploratory activity which was followed 
by tremors of the vibrissal muscles, shivering, forelimb clonus with increasing frequency 
conducting to the development of generalized tonic-clonic seizure with loss of postural 
control. After a postictal period of 10 20 min, some of the animals displayed generalized 
seizure again.  
The seizure symptoms were registered according to a scale established by Racine: mouth 
and facial movements (stage 1), head nodding and muscle tremor (stage 2), forelimb clonus 
(stage 3), rearing (stage 4) and generalized tonic-clonic seizure (GTCS, stage 5), with 
complete loss of postural control. The average latency of the first GTCS was 30.3 min (±1.4 
min).   
4.1.2. Chronic seizure model 
During the 12 days treatment the above-mentioned seizure symptoms were detected every 
day, although the severity and the stages showed slight variations. 
The analysis of the daily elicited seizure symptoms according to the Racine scale proved 
that the convulsion pattern changing slightly towards the end of the experiment: decreases of 
the seizure intensity were observed, i.e. after 4-AP administration the animals developed a 
single full motor seizure (stage 5) instead of two seizures, or displayed less severe, stage 4, 
symptoms.  
4.1.3. Lateral entorhinal cortex ablation 
In the LECA group (n = 7) only three animals responded to 4-AP injection with a single 
seizure and the remaining four animals produced no seizure at all. In the SOC group the first 
seizure lasted for 55.5 ± 4.2 s, and developed during the first 30 min following the 4-AP 
injection with an average latency of 20.8 ± 6.4 min. These events were followed by a second 
seizure within the first hour following the 4-AP treatment. The mean delay between the two 
seizures was 16.2 ± 4.9 min. The second seizure was longer, lasted for 73.4 ± 13.9 s. In the  
LECA group the latency of first seizure increased to 31.8 ± 4.3 min, and only one rat 
presented a second epileptic event.  
4.2. Immunohistochemical results  
2.1. Seizure induced c-fos 
The c-fos IR cell nuclei were present in every layer of the somatosensory neocortex 
following 4-AP administration. The increase of the number of c-fosIR cell nuclei was 
significant already at 30 min in layers II, III, IV, V and VI. The highest values were detected 
at 1 h in each layer. The increase was still significant at 3 h following 4-AP injection. Cell 
counts decreased to control levels at 5 and 8 h following 4-AP administration. The highest 
elevation in the number of c-fosIR cells at 30 min was seen in layer IV: other layers 
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contained less c-fosIR cells. At 1 h, every layer (except layer I) stained strongly; only layer 
V stood out with a lower amount of c-fos IR cells. At 3 h, the number of c-fos IR cells 
decreased to control levels, and remained so at 8 h. The values in convulsing animals 
displayed highly significant differences (P 0.01) compared to the controls. In controls, 
scattered c-fosIR cells were seen in layer IV.  
4.2.2. Seizure induced c-fos after lateral entorhinal cortex 
Convulsions induced by 4-AP 40 days after the surgery caused the expression of c-fos 
protein in every part of the hippocampus and the subiculum. The overall pattern of c-fosIR 
in SOC and LECA animals 3 h after the 4-AP injection was similar to the previous findings 
obtained with intact animals (Mihály et al. 2001, 2005; Szakács et al. 2003): strong c-fosIR 
in the dentate granule cell layer, medium c-fosIR in the stratum pyramidale of CA1 3, and 
scattered c-fosIR nuclei in the hilum of the dentate gyrus, and in the infra- and 
suprapyramidal layers of CA1 3. Quantitative analysis of immunostained cell nuclei 
revealed that the convulsions in LECA animals induced significantly less c-fos 
immunopositive cells in the pyramidal cell layer of the Ammon s horn, and in the granule 
cell layer and in the hilum of the dentate gyrus, compared with the SOC group. Because the 
number of the haematoxylin eosin-stained cell bodies did not change in LECA brains, the 
significant reduction in the number of c-fos immunopositive cells indicates the decrease of 
neuronal activity, and not the loss of neurons in the investigated hippocampal regions.  
4.2.3. FosB 
The FosB immunohistochemistry revealed a very weak labeling in the Ammon s horn of 
both the control and 4-AP treated rats in every time-course group. A very small number of 
weakly labeled cell nuclei were found in this hippocampal region and it was therefore not 
evaluated by statistical analysis. The dentate gyrus was characterized by more striking FosB 
immunolabeling. There was a significant increase in FosB-immunopositivity in the 4-AP 
treated animals compared with controls after 4, 8 and 12 days of treatment. Increase in 
immunopositivity after a single 4-AP treatment did not reach statisitical significance in 
comparison to the corresponding control level. Neocortical FosB immunoreactivity 
increased significantly after 4-AP elicited convulsions at every time point compared to 
controls. Sections stained with cresyl violet showed no gross cell loss.  
4.2.4. Parvalbumin in the medial mammillary nucleus 
The PV immunoreactivity in the MM was similar to that described (Celio, 1990). Medium-
sized neurons with few dendritic processes contained PV-like staining. Regional densities of  
immunolabeled cell bodies were determined for each experimental group. Values from 4-AP 
treated groups were compared to those from corresponding control groups (independent 
samples Student s ttest, p<0.05). The number of PV-immunoreactive neurons did not 
change in 4-AP-treated animals, compared to the controls, although the intensity of the 
staining did show a visible decrease. No pathological cell forms were detected in the 12 days 
4-AP samples.  
4.2.5. PV and FosB in the cortex 
In the brain sections from animals treated for 12 days from both 4-AP injected and control 
animals, parvalbumin-positive neurons were distributed in every layer of the frontal cortex. 
In the hippocampus, parvalbumin-positive neurons were present mainly in the pyramidal 
layer of the Ammon s horn and in the hilar region, while the granule cell layer comprised 
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scattered parvalbumin-immunopositive cells. No significant changes were revealed in the 
overall number of parvalbumin-immunopositive cells in any of the investigated brain 
regions after 4-AP treatment. There was, however, a significant increase in double-labeled 
neurons after 4-AP treatment in comparison to control levels in the neocortex, hilum of the 
dentate gyrus and region CA.   
4.3. Western blotting of the mammillary area  
PV immunoreactive bands were sharp. The samples from control and 4-AP-treated rats 
displayed a visible density difference. Densitometry of the membranes revealed a 
20.1±5.5% decrease of PV signal intensity in rat MM treated with 4-AP for 12 days, 
compared to the controls (data from eight samples of convulsing brains and seven samples 
from controls). The difference between control and 4-AP-treated values was significant 
(p<0.05).  
4.4. Quantification of regional PV mRNA contents in the rat brain following acute and 
chronic 4-AP treatment  
Regional quantities of PV mRNAs in the brains of rats subjected to acute or chronic 4-AP 
treatment were assessed by ISH employing PV [35S]cRNA probes. Autoradiograms of 
sections hybridized with antisense PV [35S]cRNA probes displayed a characteristic labeling 
pattern specific for PV mRNAs. Images of sections hybridized with sense PV [35S]cRNAs 
had very low level of labeling and did not exhibit brain structure specific signals. Normal 
distribution of experimental data was confirmed for each data set except that of group 12 
days 4-AP medial mammillary nucleus. In this group, several data points with very similar 
values compromised the normal distribution of data (skewness) even when the number of 
measurements was doubled by quantifying contralateral as well. The subnuclei of the medial 
mammillary nucleus (MM) could not be separated on the ISH images. The PV mRNA 
content of the forebrain regions of the 4- AP treated rats were compared to that of the 
corresponding control rats by using two-tailed Student s t-test (p<0.01). None of the 
investigated neocortical and allocortical areas displayed changes in PV mRNA levels in our 
experiments. Daily convulsions induced by 4-AP through 12 days did not have any impact 
on the transcription of the PV gene in the cerebral cortex. In the diencephalon, PV mRNA 
levels displayed a slight increase in group 3 h in the thalamic reticular nucleus (nRt) (116%), 
while in group 12 days significant decreases (77%, n=20, p<0.001) were observed in the 
MM of the hypothalamus. Data sets were also compared with ANOVA followed by post hoc 
Bonferroni test ( p<0.05). When regional PV mRNA abundances in 4-AP groups were 
compared to those in the corresponding controls groups, ANOVA and Bonferroni tests 
indicated that changes of the nRt of the thalamus are not significant. Data sets of MM were 
further analysed with the nonparametric Median test, which reinforced that the decrease of 
PV mRNA level in group 12 days 4-AP in the MM was highly significant, when compared 
to 12 days control value, confirming the results for this brain region obtained with the above 
parametric tests. The decreased level of PV mRNA in the MM was visible on the in situ 
hybridization images, too.     
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5. CONCLUSIONS  
The acute 4-AP seizure model provided a tool for the study of the development of 
generalized seizure activity in the rat brain. Time-dependent expression of 
neocortical c-fos correlated with electrophysiological analysis supported the 
importance of the thalamo-corticothalamic circuit in the activation and maintanace 
of the neocortical seizure, and suggested a proconvulsant role of the 
transcriptional activity of c-fos. The ablation of the entorhinal cortex is followed 
by the suppression of seizure activity and c-fos expression, suggesting  the 
importance of the limbic structures for seizure generation after systemically 
applied K+ channel blocker. 
Daily injections of  the convusing dose of 4-AP demonstrate changes in  
excitability and long-lasting expression of FosB. The symptoms of the first 4-AP 
treatment were usually characterized by the development of generalized tonic-
clonic seizures. Then, after an interval of tolerance to seizure occurence of 
sensitization was observed followed by a further desensitization period towards 
the 12th day. This is in accordance with literature data concerning the differential 
regulation of gene expression by FosB and its isoforms depending on the duration 
and level of expression. Therefore, the expression of FosB appeared to have 
protective effect against seizure and cell damage in an initial period of repeated 
brief generalized seizure sequence, and the cortical expression involved mainly 
the neocortex and dentate gyrus and proved to be protective also for the 
hippocampus proper where no cell death was observed. 
 
A large number of parvalbumin containing cells expressed FosB in the neocortex 
and regions of the hippocampal formation, suggesting  plasticity changes of 
inhibitory neurons after chronic seizure activity. In our experiments, the only brain 
region presenting alteration of parvalbumin expression was the medial 
mammillary nucleus, where the preserved number of PV positive cells had 
significantly decreased PV content.                   
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